# Tonix Pharmaceuticals Holding Corp. (TNXP): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Tonix Pharmaceuticals Holding Corp. (TNXP) is 14/100, ranked against 24,000+ stocks in 35 markets (Quality 31, Value 39, Momentum 22, each scored against its sector).

- StockRank: 14/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 31, Value 39, Momentum 22: each a 0-100 percentile within Healthcare.
- Position: #22,660 overall, #2,109 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 5.3 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 172K.
- Buybacks, last 180 days: the company bought back USD 5.9M on 1 day.

Source: https://moatmap.ai/stock/TNXP
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker